Fred Joseph Schnell

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antisense oligomers and methods of using the same for treating dise...
- Patent number 12,139,709
- Issue date Nov 12, 2024
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligomer compounds
- Patent number 11,555,189
- Issue date Jan 17, 2023
- Sarepta Therapeutics, Inc.
- Frederick J. Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 11,491,238
- Issue date Nov 8, 2022
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 11,338,041
- Issue date May 24, 2022
- Sarepta Therapeutics, Inc.
- Gunnar J. Hanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligomers and methods of using the same for treating dise...
- Patent number 11,060,089
- Issue date Jul 13, 2021
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compounds for treatment of lymphocyte-related diseases...
- Patent number 11,020,417
- Issue date Jun 1, 2021
- Sarepta Therapeutics, Inc.
- Dan V. Mourich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense-induced exon exclusion in myostatin
- Patent number 11,015,200
- Issue date May 25, 2021
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 10,765,760
- Issue date Sep 8, 2020
- Sarepta Therapeutics, Inc.
- Gunnar J. Hanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 10,758,629
- Issue date Sep 1, 2020
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antisense modulation of interleukins 17 and 23 signaling
- Patent number 9,238,042
- Issue date Jan 19, 2016
- Sarepta Therapeutics, Inc.
- Frederick J. Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20240344067
- Publication date Oct 17, 2024
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20240042049
- Publication date Feb 8, 2024
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGOMER COMPOUNDS
- Publication number 20230407301
- Publication date Dec 21, 2023
- Sarepta Therapeutics, Inc.
- Frederick J. SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20230110479
- Publication date Apr 13, 2023
- Sarepta Therapeutics, Inc.
- Gunnar J. Hanson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20220364084
- Publication date Nov 17, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISE...
- Publication number 20220364085
- Publication date Nov 17, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20220251551
- Publication date Aug 11, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN
- Publication number 20220090084
- Publication date Mar 24, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220056442
- Publication date Feb 24, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20220017901
- Publication date Jan 20, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOUNDS FOR TREATMENT OF LYMPHOCYTE-RELATED DISEASES...
- Publication number 20210283170
- Publication date Sep 16, 2021
- Sarepta Therapeutics, Inc.
- Dan V. Mourich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20210220386
- Publication date Jul 22, 2021
- Sarepta Therapeutics, Inc.
- Marco A. PASSINI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20210138078
- Publication date May 13, 2021
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20210138079
- Publication date May 13, 2021
- Sarepta Therapeutics, Inc.
- Gunnar J. Hanson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTISENSE OLIGOMER COMPOUNDS
- Publication number 20210130822
- Publication date May 6, 2021
- Sarepta Therapeutics, Inc.
- Frederick J. SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20210102205
- Publication date Apr 8, 2021
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY
- Publication number 20200190516
- Publication date Jun 18, 2020
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20190365918
- Publication date Dec 5, 2019
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20190365919
- Publication date Dec 5, 2019
- Sarepta Therapeutics, Inc.
- Gunnar J. Hanson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20190330624
- Publication date Oct 31, 2019
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISE...
- Publication number 20190284555
- Publication date Sep 19, 2019
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN
- Publication number 20180355358
- Publication date Dec 13, 2018
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
- Publication number 20180216111
- Publication date Aug 2, 2018
- Sarepta Therapeutics, Inc.
- Stephen Donald WILTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOUNDS FOR TREATMENT OF LYMPHOCYTE-RELATED DISEASES...
- Publication number 20180161359
- Publication date Jun 14, 2018
- Sarepta Therapeutics, Inc.
- Dan V. Mourich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20170369876
- Publication date Dec 28, 2017
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20140329881
- Publication date Nov 6, 2014
- SAREPTA THERAPEUTICS, INC.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE MODULATION OF INTERLEUKINS 17 AND 23 SIGNALING
- Publication number 20110289608
- Publication date Nov 24, 2011
- AVI BioPharma, Inc.
- Frederick J. Schnell
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Fred Joseph Schnell

Person

Patents Grantslast 30 patents

Antisense oligomers and methods of using the same for treating dise...

Antisense oligomer compounds

Exon skipping oligomer conjugates for muscular dystrophy

Exon skipping oligomer conjugates for muscular dystrophy

Antisense oligomers and methods of using the same for treating dise...

Methods and compounds for treatment of lymphocyte-related diseases...

Antisense-induced exon exclusion in myostatin

Exon skipping oligomer conjugates for muscular dystrophy

Exon skipping oligomer conjugates for muscular dystrophy

Antisense modulation of interleukins 17 and 23 signaling

Patents Applicationslast 30 patents

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

ANTISENSE OLIGOMER COMPOUNDS

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISE...

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

METHODS AND COMPOUNDS FOR TREATMENT OF LYMPHOCYTE-RELATED DISEASES...

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

ANTISENSE OLIGOMER COMPOUNDS

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISE...

ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN

ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE

METHODS AND COMPOUNDS FOR TREATMENT OF LYMPHOCYTE-RELATED DISEASES...

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

ANTISENSE MODULATION OF INTERLEUKINS 17 AND 23 SIGNALING